2 unknown, 1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow Programmed Cell Death Protein 1 Inhibitor: new trials by email Literature Review of Programmed Cell Death Protein 1 Inhibitor trials Research Report on Programmed Cell Death Protein 1 Inhibitor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treating Muscle-invasive Bladder Cancer With A Non-surgical Method Consisting of Anti-PD-1 Therapy and Chemoradiation Toripalimab, Gemcitabine, Cisplatin - Muscle-Invasive Bladder Carcinoma, Programmed Cell Death Protein 1 Inhibitor | Phase 2 | Active not recruiting | Sun Yat-sen University | 71 | 2023-12-01 | 2025-12-01 |
| A Perspective, Self-control Study on the Progression of Carotid Plaques in Anti-PD-1 mAb Treated Tumor Patients by Artery Ultrasound Follow-up PD-1 immune checkpoint blockades - Plaque, Atherosclerotic, Immune Checkpoint Inhibitors | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 50 | 2021-10-08 | 2021-11-17 | |
| Multi-center Observational Study on the Progression of Atherosclerotic Plaques in Anti-PD-1 mAb Treated Tumor Patients by Artery Ultrasound Follow-up PD-1 inhibitor - Plaque, Atherosclerotic, Programmed Cell Death Protein 1 Inhibitor | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 50 | 2019-11-01 | 2021-06-10 |
Plaque, Atherosclerotic (2) · Carotid Intimal Medial Thickness 1 (1) · Carotid Stenosis (1) · Urinary Bladder Neoplasms (1)
Pathological Conditions, Anatomical (2) · Pathological Conditions, Signs and Symptoms (2) · Arterial Occlusive Diseases (1) · Brain Diseases (1) · Cardiovascular Diseases (1) · Carotid Artery Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Male Urogenital Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Nervous System Diseases (1) · Urinary Bladder Diseases (1)
Carboplatin (1) · Cisplatin (1) · Gemcitabine (1) · Immune Checkpoint Inhibitors (1) · Radiotherapy, Intensity-Modulated (1) · toripalimab (1)
Second Affiliated Hospital, Zhejiang University, School of Medicine (2) · Sun Yat-sen University (1)
China (3)
Jianan Wang, MD, PhD (1) · Yuanhong Gao, MD (1)
PMID 12468791, PMID 12706187, PMID 21774709, PMID 22541275, PMID 26493239, PMID 30954372